Complete Filing Data
Sight Sciences, Inc. reported Stockholders Equity of $63.94 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Sight Sciences, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income * | -$38.4M | -$51.5M | -$55.5M | -$86.2M | -$63.0M | -$34.7M |
| Selling General And Administrative Expense | $89.2M | $100.8M | $108.9M | $120.1M | $76.2M | $41.7M |
| Revenue From Contract With Customer Excluding Assessed Tax | $77.4M | $79.9M | $81.1M | $71.3M | $49.0M | $27.6M |
| Research And Development Expense | $14.6M | $18.0M | $17.6M | $22.9M | $15.6M | $8.9M |
| Other Nonoperating Income Expense | -$148.0K | -$32.0K | -$44.0K | $2.2M | -$6.9M | -$71.0K |
| Operating Income Loss | -$37.1M | -$50.5M | -$57.3M | -$84.0M | -$51.5M | -$32.2M |
| Operating Expenses | $103.8M | $118.8M | $126.4M | $142.9M | $91.8M | $50.6M |
| Interest Expense | $5.1M | $4.7M | $5.4M | $4.5M | $4.4M | $2.4M |
| Income Tax Expense Benefit | $10.0K | $236.0K | $110.0K | $47.0K | $188.0K | $61.0K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$38.4M | -$51.3M | -$55.4M | -$86.2M | -$62.8M | -$34.6M |
| Gross Profit | $66.7M | $68.3M | $69.2M | $59.0M | $40.3M | $18.4M |
| Cost Of Goods And Services Sold | $10.7M | $11.6M | $11.9M | $12.4M | $8.6M | $9.2M |
| Noncash Operating Lease Cost | $498.0K | $646.0K | $1.0M | $542.0K | $569.0K | $563.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$8.2M | -$11.9M | -$14.2M | -$11.1M | -$12.3M | -$16.3M | -$13.0M | -$14.8M | -$17.1M | -$22.2M | -$23.8M | -$23.3M | -$17.2M | -$17.6M | -$12.2M | -$8.1M | -$8.3M | -$9.2M |
| Selling General And Administrative Expense | $21.8M | $23.9M | $24.5M | $23.4M | $26.7M | $26.6M | $26.5M | $30.1M | $28.7M | $31.5M | $31.4M | $28.4M | $20.8M | $17.8M | $14.6M | $11.2M | $7.7M | |
| Revenue From Contract With Customer Excluding Assessed Tax | $19.9M | $19.6M | $17.5M | $20.2M | $21.4M | $19.3M | $20.0M | $23.5M | $18.8M | $18.7M | $17.2M | $14.9M | $13.1M | $12.5M | $8.6M | $8.7M | $3.5M | |
| Research And Development Expense | $3.4M | $4.4M | $4.4M | $4.7M | $4.3M | $4.6M | $4.2M | $5.2M | $4.7M | $6.1M | $5.9M | $5.6M | $4.3M | $3.5M | $3.4M | $2.2M | $1.4M | |
| Other Nonoperating Income Expense | -$2.0K | $24.0K | -$139.0K | $26.0K | -$44.0K | -$8.0K | -$11.0K | -$3.0K | -$19.0K | $766.0K | $95.0K | -$15.0K | -$2.0M | -$5.4M | $552.0K | -$197.0K | -$73.0K | |
| Operating Income Loss | -$7.9M | -$11.7M | -$13.9M | -$11.2M | -$12.7M | -$14.7M | -$13.4M | -$15.2M | -$17.6M | -$21.8M | -$22.9M | -$22.2M | -$14.0M | -$11.1M | -$11.7M | -$7.4M | -$7.7M | |
| Operating Expenses | $25.1M | $28.3M | $29.0M | $28.1M | $31.0M | $31.2M | $30.7M | $35.3M | $33.3M | $37.6M | $37.4M | $34.0M | $25.1M | $21.3M | $18.0M | $13.4M | $9.1M | |
| Interest Expense | $1.3M | $1.3M | $1.3M | $1.2M | $1.1M | $1.2M | $1.4M | $1.3M | $1.3M | $1.1M | $1.1M | $1.0M | $1.1M | $1.1M | $1.1M | $538.0K | $549.0K | |
| Income Tax Expense Benefit | -$79.0K | $40.0K | $41.0K | $166.0K | $15.0K | $17.0K | $78.0K | $8.0K | $14.0K | $19.0K | $9.0K | $9.0K | $16.0K | $22.0K | $52.0K | $8.0K | $6.0K | |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$8.2M | -$11.9M | -$14.1M | -$10.9M | -$12.3M | -$16.2M | -$13.0M | -$14.7M | -$17.1M | -$22.2M | -$23.8M | -$23.3M | -$17.2M | -$17.6M | -$12.2M | -$8.1M | -$8.3M | |
| Gross Profit | $17.2M | $16.6M | $15.1M | $16.9M | $18.3M | $16.5M | $17.3M | $20.1M | $15.8M | $15.7M | $14.5M | $11.8M | $11.0M | $10.2M | $6.3M | $6.0M | $1.4M | |
| Cost Of Goods And Services Sold | $2.7M | $3.0M | $2.4M | $3.3M | $3.0M | $2.8M | $2.7M | $3.4M | $3.0M | $2.9M | $2.7M | $3.0M | $2.1M | $2.3M | $2.3M | $2.6M | $2.1M | |
| Noncash Operating Lease Cost | $119.0K | $160.0K | $242.0K | $121.0K | $156.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | $63.9M | $87.5M | $120.2M | $160.1M | $232.1M | -$88.8M | -$54.7M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $92.2M | $120.4M | $138.1M | $185.0M | $260.7M | $61.5M | $21.2M |
| Operating Lease Right Of Use Asset | $438.0K | $935.0K | $1.5M | $1.6M | $1.5M | $518.0K | |
| Issuance Of Common Stock Upon Exercise Of Stock Options | $1.1M | $255.0K | $395.0K | $576.0K | |||
| Cash And Cash Equivalents At Carrying Value | $92.0M | $120.4M | $138.1M | $185.0M | $260.7M | $61.5M | |
| Retained Earnings Accumulated Deficit | -$384.7M | -$346.3M | -$294.8M | -$239.2M | -$153.0M | -$90.0M | |
| Property Plant And Equipment Net | $1.6M | $1.6M | $1.6M | $1.6M | $1.5M | $1.3M | |
| Prepaid Expense And Other Assets Current | $3.3M | $2.3M | $2.6M | $3.4M | $4.2M | $1.2M | |
| Other Liabilities Noncurrent | $31.0K | $492.0K | $2.5M | $1.9M | $1.9M | $3.1M | |
| Other Assets Noncurrent | $518.0K | $550.0K | $682.0K | $211.0K | $202.0K | $386.0K | |
| Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 | $114.0K | $169.0K | $60.0K | $103.0K | $162.0K | $41.0K | |
| Long Term Debt Noncurrent | $40.3M | $39.4M | $31.7M | $33.3M | $32.7M | $32.0M | |
| Liabilities Current | $11.0M | $15.5M | $12.3M | $17.8M | $13.5M | $9.3M | |
| Liabilities And Stockholders Equity | $115.3M | $142.8M | $166.7M | $213.1M | $280.2M | $72.8M | |
| Liabilities | $51.4M | $55.3M | $46.4M | $53.0M | $48.1M | $44.3M | |
| Inventory Write Down | $0.00 | -$106.0K | $418.0K | $614.0K | $436.0K | $1.4M | |
| Inventory Net | $7.8M | $6.3M | $7.8M | $6.1M | $3.5M | $2.6M | |
| Employee Related Liabilities Current | $6.1M | $9.7M | $4.5M | $7.4M | $6.0M | $4.1M | |
| Common Stock Value | $54.0K | $51.0K | $49.0K | $48.0K | $48.0K | $9.0K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$28.1M | -$17.8M | -$46.9M | -$75.7M | $199.2M | $40.3M | |
| Assets Current | $112.7M | $139.8M | $162.9M | $209.7M | $277.0M | $70.6M | |
| Assets | $115.3M | $142.8M | $166.7M | $213.1M | $280.2M | $72.8M | |
| Additional Paid In Capital Common Stock | $448.6M | $433.8M | $415.0M | $399.3M | $385.1M | $1.2M | |
| Accounts Receivable Net Current | $9.7M | $10.8M | $14.3M | $15.1M | $8.7M | $5.4M | |
| Accounts Payable Current | $1.3M | $1.7M | $1.7M | $2.7M | $3.4M | $2.2M | |
| Accounts Payable And Other Accrued Liabilities Current | $3.6M | $4.1M | $3.8M | $7.8M | $4.2M | $3.1M | |
| Gain Loss On Sale Of Property Plant Equipment | -$4.0K | -$23.0K | -$66.0K | -$85.0K | -$115.0K | $158.0K | |
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Gains Losses On Extinguishment Of Debt | $0.00 | -$2.0M | $0.00 | ||||
| Allowance For Doubtful Accounts Receivable Current | $234.0K | $689.0K | $1.2M | $1.0M | |||
| Stock Issued During Period Value Purchase Of Assets | $758.0K | $819.0K | $933.0K | $672.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $64.3M | $70.0M | $77.6M | $95.0M | $101.6M | $109.2M | $127.1M | $136.1M | $146.4M | $172.9M | $191.8M | $211.9M | -$246.0M | -$117.3M | -$100.8M | -$80.0M | -$72.0M | -$63.8M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $92.6M | $101.5M | $108.8M | $118.6M | $118.2M | $127.3M | $144.5M | $154.5M | $167.3M | $199.8M | $220.1M | $238.6M | $271.5M | $35.6M | $48.3M | $26.8M | $35.7M | |
| Operating Lease Right Of Use Asset | $568.0K | $694.0K | $817.0K | $1.1M | $1.3M | $1.3M | $871.0K | $1.1M | $1.4M | $1.1M | $1.3M | $1.4M | $1.6M | $231.0K | $1.5M | |||
| Issuance Of Common Stock Upon Exercise Of Stock Options | $27.0K | $58.0K | $63.0K | $77.0K | $11.0K | $145.0K | $117.0K | $122.0K | $49.0K | $186.0K | $159.0K | $93.0K | ||||||
| Cash And Cash Equivalents At Carrying Value | $92.4M | $101.5M | $108.8M | $118.6M | $118.2M | $127.3M | $144.5M | $154.5M | $167.3M | $199.8M | $220.1M | $238.6M | $271.5M | $35.6M | ||||
| Retained Earnings Accumulated Deficit | -$380.6M | -$372.4M | -$360.5M | -$334.5M | -$323.4M | -$311.1M | -$284.1M | -$271.1M | -$256.3M | -$222.3M | -$200.1M | -$176.3M | -$137.1M | -$119.9M | ||||
| Property Plant And Equipment Net | $1.5M | $1.5M | $1.5M | $1.4M | $1.5M | $1.6M | $1.6M | $1.5M | $1.4M | $1.6M | $1.7M | $1.7M | $1.4M | $1.4M | ||||
| Prepaid Expense And Other Assets Current | $3.5M | $2.1M | $2.9M | $2.9M | $1.5M | $2.3M | $2.9M | $1.8M | $2.8M | $4.4M | $2.0M | $2.7M | $4.5M | $2.4M | ||||
| Other Liabilities Noncurrent | $66.0K | $202.0K | $347.0K | $689.0K | $1.0M | $961.0K | $1.5M | $1.5M | $1.7M | $1.8M | $1.8M | $1.9M | $2.3M | $8.1M | ||||
| Other Assets Noncurrent | $548.0K | $386.0K | $472.0K | $580.0K | $640.0K | $624.0K | $655.0K | $367.0K | $224.0K | $202.0K | $236.0K | $191.0K | $182.0K | $3.5M | ||||
| Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 | $178.0K | $0.00 | $10.0K | $418.0K | $35.0K | |||||||||||||
| Long Term Debt Noncurrent | $40.1M | $39.8M | $39.6M | $34.2M | $33.8M | $33.7M | $33.8M | $33.6M | $33.5M | $33.2M | $33.0M | $32.8M | $32.5M | $32.3M | ||||
| Liabilities Current | $11.8M | $11.9M | $12.1M | $13.8M | $13.3M | $11.7M | $14.3M | $14.1M | $15.1M | $17.4M | $14.2M | $12.0M | $10.3M | $12.1M | ||||
| Liabilities And Stockholders Equity | $116.3M | $122.0M | $129.7M | $143.6M | $149.7M | $155.6M | $176.6M | $185.3M | $196.6M | $225.2M | $240.7M | $258.6M | $291.1M | $52.5M | ||||
| Liabilities | $52.0M | $52.0M | $52.1M | $48.6M | $48.1M | $46.4M | $49.6M | $49.2M | $50.3M | $52.3M | $49.0M | $46.7M | $45.1M | $52.5M | ||||
| Inventory Write Down | -$21.0K | -$25.0K | $12.0K | $8.0K | $211.0K | |||||||||||||
| Inventory Net | $8.0M | $6.2M | $5.8M | $6.1M | $6.8M | $6.9M | $9.2M | $7.9M | $7.1M | $5.5M | $4.9M | $4.1M | $2.9M | $2.6M | ||||
| Employee Related Liabilities Current | $6.2M | $5.2M | $5.1M | $7.9M | $5.4M | $4.0M | $5.5M | $5.7M | $5.0M | $8.0M | $6.3M | $3.9M | $4.6M | $4.1M | ||||
| Common Stock Value | $52.0K | $52.0K | $51.0K | $50.0K | $50.0K | $50.0K | $49.0K | $49.0K | $48.0K | $48.0K | $48.0K | $48.0K | $49.0K | $9.0K | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$11.6M | -$10.8M | -$17.7M | -$22.1M | -$13.2M | |||||||||||||
| Assets Current | $113.6M | $119.4M | $126.9M | $140.5M | $146.3M | $152.1M | $173.6M | $182.3M | $193.7M | $222.3M | $237.5M | $255.3M | $287.8M | $47.4M | ||||
| Assets | $116.3M | $122.0M | $129.7M | $143.6M | $149.7M | $155.6M | $176.6M | $185.3M | $196.6M | $225.2M | $240.7M | $258.6M | $291.1M | $52.5M | ||||
| Additional Paid In Capital Common Stock | $444.8M | $442.4M | $438.0M | $429.4M | $425.0M | $420.2M | $411.1M | $407.1M | $402.6M | $395.2M | $391.8M | $388.1M | $383.0M | $2.6M | ||||
| Accounts Receivable Net Current | $9.7M | $9.6M | $9.4M | $12.9M | $19.9M | $15.6M | $16.9M | $18.1M | $16.4M | $12.6M | $10.5M | $9.9M | $8.9M | $6.9M | ||||
| Accounts Payable Current | $1.7M | $2.1M | $2.8M | $1.3M | $1.9M | $1.7M | $3.5M | $2.9M | $3.5M | $3.2M | $2.7M | $3.1M | $1.8M | $3.2M | ||||
| Accounts Payable And Other Accrued Liabilities Current | $3.9M | $4.6M | $4.2M | $4.6M | $6.0M | $6.0M | $5.3M | $5.4M | $6.7M | $6.2M | $5.2M | $5.1M | $3.8M | $4.8M | ||||
| Gain Loss On Sale Of Property Plant Equipment | $0.00 | -$66.0K | -$46.0K | -$4.0K | ||||||||||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| Gains Losses On Extinguishment Of Debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$2.0M | $0.00 | $0.00 | $0.00 | |||||||||
| Allowance For Doubtful Accounts Receivable Current | $224.0K | $356.0K | $629.0K | $824.0K | $1.1M | $1.0M | $1.4M | $1.0M | $774.0K | |||||||||
| Stock Issued During Period Value Purchase Of Assets | $433.0K | $450.0K | $661.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Stock Issued During Period Value Share Based Compensation | $13.1M | $17.1M | $14.6M | $13.0M | $5.1M | $497.0K |
| Share Based Compensation | $13.1M | $17.1M | $14.6M | $13.0M | $5.1M | $497.0K |
| Payments To Acquire Property Plant And Equipment | $224.0K | $385.0K | $791.0K | $970.0K | $813.0K | $953.0K |
| Net Cash Provided By Used In Operating Activities | -$29.7M | -$22.4M | -$47.2M | -$76.0M | -$52.5M | -$32.2M |
| Net Cash Provided By Used In Investing Activities | -$224.0K | -$385.0K | -$791.0K | -$970.0K | -$813.0K | -$953.0K |
| Net Cash Provided By Used In Financing Activities | $1.8M | $5.0M | $1.1M | $1.2M | $252.5M | $73.4M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $686.0K | -$299.0K | -$812.0K | -$751.0K | $3.0M | $735.0K |
| Increase Decrease In Other Noncurrent Liabilities | $0.00 | -$1.6M | $330.0K | $353.0K | $72.0K | $614.0K |
| Increase Decrease In Inventories | $1.4M | -$1.6M | $2.2M | $3.3M | $1.3M | $1.7M |
| Increase Decrease In Employee Related Liabilities | -$3.6M | $5.2M | -$2.8M | $1.4M | $1.9M | $1.9M |
| Increase Decrease In Accrued Liabilities | -$1.1M | -$347.0K | -$4.6M | $2.6M | $342.0K | $2.0M |
| Increase Decrease In Accounts Receivable | -$912.0K | -$3.5M | -$661.0K | $6.8M | $3.7M | $1.5M |
| Increase Decrease In Accounts Payable | -$348.0K | $336.0K | -$883.0K | -$694.0K | $1.2M | $448.0K |
| Increase Decrease In Other Noncurrent Assets | $150.0K | $51.0K | $470.0K | $10.0K | -$185.0K | $237.0K |
| Proceeds From Stock Options Exercised | $1.1M | $255.0K | $395.0K | $576.0K | $355.0K | $24.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Issued During Period Value Share Based Compensation | $2.4M | $3.8M | $4.2M | $4.3M | $4.3M | $4.5M | $3.9M | $3.7M | $3.5M | $3.2M | $3.5M | $3.0M | $1.9M | $931.0K | $277.0K | $165.0K | $65.0K | $61.0K |
| Share Based Compensation | $4.2M | $4.5M | $3.5M | $3.0M | $277.0K | |||||||||||||
| Payments To Acquire Property Plant And Equipment | $0.00 | $117.0K | $126.0K | $227.0K | $104.0K | |||||||||||||
| Net Cash Provided By Used In Operating Activities | -$11.6M | -$9.8M | -$17.4M | -$22.0M | -$12.9M | |||||||||||||
| Net Cash Provided By Used In Investing Activities | $0.00 | -$117.0K | -$126.0K | -$227.0K | -$104.0K | |||||||||||||
| Net Cash Provided By Used In Financing Activities | $16.0K | -$942.0K | -$156.0K | $92.0K | -$210.0K | |||||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $604.0K | -$317.0K | -$593.0K | -$1.5M | -$122.0K | |||||||||||||
| Increase Decrease In Other Noncurrent Liabilities | $0.00 | -$1.4M | $77.0K | $86.0K | $91.0K | |||||||||||||
| Increase Decrease In Inventories | -$541.0K | -$1.0M | $1.0M | $615.0K | $146.0K | |||||||||||||
| Increase Decrease In Employee Related Liabilities | -$4.6M | -$501.0K | -$2.4M | -$2.1M | -$1.8M | |||||||||||||
| Increase Decrease In Accrued Liabilities | -$19.0K | $2.1M | -$1.3M | $472.0K | $977.0K | |||||||||||||
| Increase Decrease In Accounts Receivable | -$1.3M | $1.4M | $959.0K | $1.2M | $301.0K | |||||||||||||
| Increase Decrease In Accounts Payable | $1.1M | $371.0K | $878.0K | -$248.0K | $1.1M | |||||||||||||
| Increase Decrease In Other Noncurrent Assets | -$32.0K | -$12.0K | $13.0K | -$10.0K | $1.0M | |||||||||||||
| Proceeds From Stock Options Exercised | $63.0K | $145.0K | $49.0K | $92.0K | $13.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.74 | -$1.03 | -$1.14 | -$1.80 | -$2.36 | -$3.71 |
| Weighted Average Number Of Shares Outstanding Basic | 52.1M | 50.1M | 48.6M | 47.8M | 26.7M | |
| Weighted Average Number Of Diluted Shares Outstanding | 52.1M | 50.1M | 48.6M | 47.8M | 26.7M | |
| Earnings Per Share Basic | $-0.74 | $-1.03 | $-1.14 | $-1.80 | $-2.36 | |
| Common Stock Shares Outstanding | 53.5M | 50.9M | 49.1M | 48.3M | 47.5M | 9.5M |
| Common Stock Shares Issued | 53.5M | 50.9M | 49.1M | 48.3M | 47.5M | 9.5M |
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 21.8M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Restricted Stock Value Shares Issued Net Of Tax Withholdings | -58.0K | -23.0K | -224.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.16 | -$0.23 | -$0.28 | -$0.22 | -$0.25 | -$0.33 | -$0.27 | -$0.30 | -$0.35 | -$0.46 | -$0.50 | -$0.49 | -$0.43 | -$1.83 | -$1.29 | -$0.85 | -$0.88 |
| Weighted Average Number Of Shares Outstanding Basic | 52.4M | 51.8M | 51.3M | 50.3M | 49.9M | 49.5M | 48.7M | 48.5M | 48.4M | 47.9M | 47.7M | 47.6M | 39.8M | ||||
| Weighted Average Number Of Diluted Shares Outstanding | 52.4M | 51.8M | 51.3M | 50.3M | 49.9M | 49.5M | 48.7M | 48.5M | 48.4M | 47.9M | 47.7M | 47.6M | 39.8M | ||||
| Earnings Per Share Basic | $-0.16 | $-0.23 | $-0.28 | $-0.22 | $-0.25 | $-0.33 | $-0.27 | $-0.30 | $-0.35 | $-0.46 | $-0.50 | $-0.49 | $-0.43 | ||||
| Common Stock Shares Outstanding | 52.5M | 52.0M | 51.4M | 50.4M | 50.1M | 49.6M | 48.3M | 48.6M | 48.5M | 48.1M | 47.8M | 47.6M | 47.3M | 9.7M | |||
| Common Stock Shares Issued | 52.5M | 52.0M | 51.4M | 50.4M | 50.1M | 49.6M | 48.7M | 48.6M | 48.5M | 48.1M | 47.8M | 47.6M | 47.3M | 9.7M | |||
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 21.8M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | |||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Restricted Stock Value Shares Issued Net Of Tax Withholdings | -1.0K | -7.0K | -47.0K | -20.0K | -17.0K | -205.0K |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Provision For Doubtful Accounts | $129.0K | -$42.0K | $198.0K | $402.0K | $348.0K | $209.0K |
| Interest Paid Net | $4.2M | $4.3M | $4.3M | $3.3M | $3.1M | $1.3M |
| Amortization Of Financing Costs And Discounts | $944.0K | $753.0K | $614.0K | $657.0K | $701.0K | $574.0K |
| Depreciation | $614.0K | $710.0K | $632.0K | $554.0K | ||
| Taxes Paid On The Net Share Settlement Of Restricted Stock Units | -$58.0K | -$23.0K | -$224.0K | $0.00 | ||
| Investment Income Net | $4.0M | $5.9M | $7.3M | |||
| Stock Issued During Period Value Stock Options Exercised | $672.0K | $355.0K | $24.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Provision For Doubtful Accounts | $35.0K | $36.0K | -$250.0K | -$60.0K | $27.0K | |||||||||||||
| Interest Paid Net | $1.0M | $1.1M | $1.0M | $766.0K | $766.0K | |||||||||||||
| Amortization Of Financing Costs And Discounts | $228.0K | $94.0K | $144.0K | $161.0K | $170.0K | |||||||||||||
| Depreciation | $200.0K | $100.0K | $146.0K | $200.0K | $200.0K | $179.0K | $200.0K | $200.0K | $135.0K | $100.0K | $200.0K | |||||||
| Taxes Paid On The Net Share Settlement Of Restricted Stock Units | -$47.0K | $0.00 | -$205.0K | $0.00 | ||||||||||||||
| Investment Income Net | $965.0K | $1.0M | $1.1M | $1.5M | $1.5M | $1.6M | $1.9M | $1.8M | $1.8M | |||||||||
| Stock Issued During Period Value Stock Options Exercised | $159.0K | $93.0K | $57.0K | $196.0K | $11.0K | $12.0K | $7.0K | $1.0K |
Most recent annual filing with the SEC: March 4, 2026
Data sourced from SEC EDGAR public filings as of August 4, 2026.